Angelini Pharma and Sovargen Partner to Advance Brain Health Innovations
Seoul: Angelini Pharma, a member of Angelini Industries, and Sovargen, a biotechnology company based in South Korea, have entered into an exclusive global option agreement to develop and commercialise SVG105, an innovative asset in brain health.
Acc…